20 results
6-K
EX-99.1
LEGN
Legend Biotech Corp
14 Apr 23
Master Technology Transfer, Manufacturing and Clinical Supply Services Agreement for Bcma Car-t Product
8:30am
the meaning set forth in Section 16.4 (Training).
“Losses” has the meaning set forth in Section 17.1 (Indemnification by Provider).
Page 5 of 61 … their presence in the Facilities including any training requirements, and will be required to be escorted by Provider Personnel during any observation
6-K
EX-99.1
33ze3r9kgvn2q7tua
26 May 22
Legend Biotech Corp. 6-K
6:02am
6-K
EX-99.1
ar771tjc
1 Apr 22
Legend Biotech Corp. 6-K
4:01pm
6-K
EX-99.1
uam82pxq942p2jx8p
1 Mar 22
Legend Biotech Corp. 6-K
6:00am
20-F
ntp fsm69etuvyng5
2 Apr 21
Annual report (foreign)
8:10am
6-K
EX-99.1
8nwl 9cx8z688xldd6y7
3 Dec 20
Legend Biotech Announces Appointment of Dr. Patrick Casey to the Board of Directors
8:08am
424B4
cdi wm69yy1m7a3ab
8 Jun 20
Prospectus supplement with pricing info
9:07am
F-1/A
EX-10.8
kbxz4
29 May 20
Registration statement (foreign) (amended)
8:32am
F-1/A
3bs3t ajwwv
29 May 20
Registration statement (foreign) (amended)
8:32am
F-1
EX-10.1
a9kqafh72
13 May 20
Registration statement (foreign)
4:41pm
F-1
5ovfgfb9
13 May 20
Registration statement (foreign)
4:41pm
F-1
EX-10.8
siah3gn
13 May 20
Registration statement (foreign)
4:41pm
DRS/A
od1mntsf1h3q
8 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.1
d64y624vetej
8 May 20
Draft registration statement (amended)
12:00am
DRS/A
qtzk6k7wz 8rso431q
20 Apr 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next